| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |